CCI4EU - Effective Patient Pathways
Recordings from CCI4EU 3rd Capacity Buiding Conference
CCI4EU - Effective Patient Pathways
Recordings from CCI4EU 3rd Capacity Buiding Conference
The Conference Effective Patient Pathways was held in Madrid, Spain, on 15 and 16 October 2025 and all interventions were recorded and are now available via these pages (to access the material, participants must register to the online course, login to the e-ESO platform and click on the PLAY buttons inside the programme). The event, the last of three conferences, gave individuals and teams from developing CCIs direction in helping them build their capacity and develop their infrastructures.
The gap between research findings and clinical implementation poses a significant challenge in healthcare. Bridging this gap is essential to ensure that the latest evidence is incorporated into patient care effectively. This conference was aimed at professionals involved in translational research, clinical trialists, directors of science and hospital leaders.
WELCOME & INTRODUCTION
Welcome from the Director of the Cancer Center Clínica Universidad de Navarra and from the OECI President
Giovanni Apolone (IT) Antonio González Martín (ES)Introduction
Alexandre Brutti (FR) Simon Oberst (BE) Claudia M Valverde (ES) Yvonne Wengstrom (SE)DEVELOPMENT AND ITS DIFFICULTIES
Pathway development
Peggy Richter (DE)The breast cancer pathway - an example
Daniela Martin (RO)A cross-institutional patient pathway
Daniëlle Holthuijsen (NL)Contiuous improvement of patient pathways in collaboration - a Karolinska CCC example
Ann-Britt Johansson (SE) Anita Wanngren (SE)Continued development of pathways in collaboration with patients (patient perspective)
Caitriona Higgins (IE)Discussion
IMPLEMENTATION
MDTs - optimizing participation for everyone in the health care team
Erik van Muilekom (NL)The role of the patient navigator/case manager
Laura Lonergan (IE)Introducing a shared decission-making program
Bettina Mølri Knudsen (DK)Developing survivorship care programs in the CCC setting
Ana Carolina Izurieta Pacheco (ES)Discussion
RESEARCH IN THE PATIENT PATHWAY
How to improve recruitment to CTs?
Esmee Volders (NL)How to increase the number of academic CTs?
Nadia Hindi (ES)What are the key human infrastructures needed to support CTs?
Eduardo Castañón (ES)Discussion
EVALUATION
Assessing the pathway using KPI data
Ann-Britt Johansson (SE)Assessment and improvement of multidisciplinary teams - AEMAC experience as an example
Karla Salas Gama (ES)Can AI be used to optimize the patient pathway?
Arsela Prelaj (IT)Discussion
Closing remarks
Alexandre Brutti
Paris, FR
Ana Carolina Izurieta Pacheco
Hospital Sant Joan de Déu, Barcelona, Pediatric Oncology, Esplugues de Llobregat, ES
Anita Wanngren
Karolinska Comprehensive Cancer Center, Patient representative, Stockholm, SE
Ann-Britt Johansson
Karolinska Comprehensive Cancer Center, Coordinator at Karolinska Comprehensive Cancer Center, Stockholm, SE
Antonio González Martín
Clínica Universidad de Navarra, Oncology Dept., Madrid, ES
Arsela Prelaj
Fondazione IRCCS Istituto Nazionale Tumori, Thoracic Oncology Unit, Milan, IT
Bettina Mølri Knudsen
Lillebaelt Hospital - University Hospital of Southern Denmark, Center for Shared Decision Making, Vejle, DK
Caitriona Higgins
Beaumont Hospital, Cancer Directorate Dpt., Dublin 9, IE
Claudia M Valverde
Vall d´Hebrón University Hospital, Medical Oncology Dpt., Barcelona, ES
Daniela Martin
Cancer Institute "Prof. Dr. I. Chiricuta", Dept. of Radiotherapy, Cluj-Napoca, RO
Daniëlle Holthuijsen
OncoZON, Policy advisor OncoZON, Maastricht, NL
Eduardo Castañón
University of Navarra, Medical Oncology, Madrid, ES
Erik van Muilekom
Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Urology Dpt., Amsterdam, NL
Esmee Volders
Oncozon / Maastricht Umc+, Maastricht Comprehensive Cancer Center, Maastricht, NL
Giovanni Apolone
Fondazione IRCCS Istituto Nazionale dei Tumori, Direzione Scientifica, Milano, IT
Karla Salas Gama
Hospital Universitari Vall d’Hebron, Coordinadora Unitat de Qualitat i Millora de la Pràctica Clínica, Barcelona, ES
Laura Lonergan
St James’s Hospital, Clinical Nurse Manager III, Dublin 8, IE
Nadia Hindi
Hospital Fundación Jimenez Díaz, Medical Oncology, Madrid, ES
Peggy Richter
TUD Dresden University of Technology, Research Group Digital Health Dpt., Dresden, DE
Simon Oberst
Yvonne Wengstrom
Karolinska Insitutet, Department of Neurobiology, Care Science and Society, Div. of Nursing, Huddinge, SE
